Shareholders Equity: The sum of preferred and common equity items.
Sana Biotechnology, Inc. (SANA) had Shareholders Equity of $287.51M for the most recently reported fiscal year, ending 2023-12-31.
Income Statement Financials | |
-- |
|
$-283.25M |
|
-- |
|
-- |
|
$293.14M |
|
$-293.14M |
|
$9.89M |
|
$-283.25M |
|
$-283.25M |
|
$-283.25M |
|
$-283.25M |
|
$-283.25M |
|
$-283.25M |
|
$-293.14M |
|
$-268.58M |
|
194.54M |
|
194.54M |
|
$-1.46 |
|
$-1.46 |
|
Balance Sheet Financials | |
$213.51M |
|
$70.69M |
|
$351.78M |
|
$565.30M |
|
$64.49M |
|
-- |
|
$213.31M |
|
$277.79M |
|
$287.51M |
|
$87.68M |
|
Shareholders Equity |
$287.51M |
197.86M |
|
Cash Flow Statement Financials | |
$-253.58M |
|
$172.01M |
|
$31.65M |
|
$187.27M |
|
$137.35M |
|
$-49.92M |
|
$35.53M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
3.31 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-273.61M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-98.52% |
|
-323.04% |
|
-50.11% |
|
-98.52% |
|
$1.45 |
|
$-1.41 |
|
$-1.30 |